ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 400,28
-0,77%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Enochian Biosciences Inc (ENOB)

  7. Enochian Biosciences Inc (ENOB) Actualités

ENOB Enochian Biosciences Inc

0,72
0,00 (0,00%)
03 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Enochian Biosciences Inc ENOB NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 0,72 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,72 0,72
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
30/4/202422:49EDGAR2Form 8-K - Current report
24/4/202423:23EDGAR2Form 8-K/A - Current report: [Amend]
08/4/202423:44EDGAR2Form SC 13D/A - General statement of acquisition of..
19/3/202416:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/3/202420:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/3/202420:45EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/3/202414:30EDGAR2Form 8-K - Current report
17/2/202400:11EDGAR2Form SC 13D/A - General statement of acquisition of..
16/2/202421:03EDGAR2Form SC 13D/A - General statement of acquisition of..
16/2/202415:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202414:35EDGAR2Form 8-K - Current report
16/2/202400:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202423:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/2/202422:33EDGAR2Form 8-K - Current report
07/2/202422:51EDGAR2Form 8-K - Current report
25/1/202423:15EDGAR2Form 8-K - Current report
24/1/202422:08EDGAR2Form SC 13D/A - General statement of acquisition of..
24/1/202422:08EDGAR2Form SC 13D/A - General statement of acquisition of..
24/1/202422:07EDGAR2Form SC 13D/A - General statement of acquisition of..
24/1/202422:07EDGAR2Form SC 13D/A - General statement of acquisition of..
24/1/202422:06EDGAR2Form SC 13D/A - General statement of acquisition of..
24/1/202422:05EDGAR2Form SC 13D/A - General statement of acquisition of..
24/1/202422:05EDGAR2Form SC 13D/A - General statement of acquisition of..
24/1/202422:04EDGAR2Form SC 13D/A - General statement of acquisition of..
24/1/202422:04EDGAR2Form SC 13D/A - General statement of acquisition of..
24/1/202422:03EDGAR2Form SC 13D/A - General statement of acquisition of..
16/1/202423:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
16/1/202423:23EDGAR2Form 8-K - Current report
16/1/202414:06EDGAR2Form 8-K - Current report
16/1/202414:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
03/1/202414:00EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
22/12/202323:25EDGAR2Form PREM14A - Preliminary proxy statements relating to..
22/12/202317:57EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/12/202323:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/12/202323:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
01/12/202323:27EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
01/12/202323:09EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
01/12/202323:08EDGAR2Form 8-K - Current report
22/11/202322:55EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
03/11/202322:25EDGAR2Form SC 13D/A - General statement of acquisition of..
02/11/202322:29EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
30/10/202314:15EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
27/10/202316:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/10/202316:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/10/202303:47EDGAR2Form S-8 - Securities to be offered to employees in employee..
19/10/202319:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202316:13EDGAR2Form 8-K - Current report
11/10/202315:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..

Dernières Valeurs Consultées

NASDAQ
ENOB
Enochian Biosciences
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés